miR‑222 regulates sorafenib resistance and enhance tumorigenicity in hepatocellular carcinoma
- Type
- Retraction
- Notice date
- 11/2/2021 0:00
- Journal
- International Journal of Oncology
- Publisher
- Spandidos
- Notice DOI
- 10.3892/ijo.2021.5280
- Original paper DOI
- 10.3892/ijo.2014.2577